Access to Medication and Drug Company Sales Practices: Setting Priorities for Critique and Advocacy

ISSN： 1536-0075

Source： American Journal of Bioethics, Vol.3, Iss.3, 2003-08, pp. : 61-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why Academic Medical Centers Should Ban Drug Company Gifts to Individuals

By Strong Carson

American Journal of Bioethics, Vol. 10, Iss. 1, 2010-01 ,pp. : 13-15

Routledge Ltd

Access to resources Recommend Favorite

Mediation and Advocacy

By Fiester Autumn

American Journal of Bioethics, Vol. 12, Iss. 8, 2012-08 ,pp. : 10-11

Routledge Ltd

Access to resources Recommend Favorite

Ethics or Advocacy?

By Sobsey Dick

American Journal of Bioethics, Vol. 10, Iss. 1, 2010-01 ,pp. : 59-60

Routledge Ltd

Access to resources Recommend Favorite

Solidarity in practices of provision: distributing access to genetic technologies in health care in Germany, the Netherlands and the United Kingdom

By Aarden Erik Van Hoyweghen Ine Horstman Klasien

New Genetics & Society, Vol. 29, Iss. 4, 2010-12 ,pp. : 369-388

Routledge Ltd

Access to resources Recommend Favorite

A Place for Ethics? A Place for Advocacy?

By Pierce Robin L.

American Journal of Bioethics, Vol. 12, Iss. 8, 2012-08 ,pp. : 17-18

Routledge Ltd

Access to resources Recommend Favorite